샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941540

세포배양 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Culture Market Size, Share & Trends Analysis Report By Product, By Application, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포배양 시장 요약

세계의 세포배양 시장 규모는 2025년에 191억 3,000만 달러로 추정되며, 2033년까지 493억 3,000만 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 12.94%로 성장할 것으로 예상됩니다. 이 산업은 주로 바이오의약품의 수요 증가, 신약개발에서 세포기반 분석법의 채택 확대, 세포배양 기술의 발전에 의해 주도되고 있습니다.

자주 묻는 질문

  • 세포배양 시장 규모는 어떻게 예측되나요?
  • 세포배양 시장의 성장 요인은 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향 및 범위

제4장 제품별 비즈니스 분석

제5장 용도별 비즈니스 분석

제6장 지역별 비즈니스 분석

제7장 경쟁 구도

KSM 26.03.13

Cell Culture Market Summary

The global cell culture market size was estimated at USD 19.13 billion in 2025 and is projected to reach USD 49.33 billion by 2033, growing at a CAGR of 12.94% from 2026 to 2033. The industry is primarily driven by the rising demand for biopharmaceuticals, increasing adoption of cell-based assays in drug discovery, and advancements in cell culture technologies.

Global Cell Culture Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell culture market report on the basis of product, application, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
    • Sera
    • Fetal Bovine Serum
    • Other
    • Reagents
    • Albumin
    • Others
    • Media
    • Serum-free Media
    • CHO Media
    • HEK 293 Media
    • BHK Medium
    • Vero Medium
    • Other Serum-free Media
    • Classical Media
    • Stem Cell Culture Media
    • Chemically Defined Media
    • Specialty Media
    • Other Cell Culture Media
  • Instruments
    • Culture Systems
    • Incubators
    • Centrifuges
    • Cryostorage Equipment
    • Biosafety Equipment
    • Pipetting Instruments
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Production
    • Monoclonal Antibodies
    • Vaccines Production
    • Other Therapeutic Proteins
  • Drug Development
  • Diagnostics
  • Tissue Culture & Engineering
  • Cell and Gene Therapy
  • Toxicity Testing
  • Other Applications
  • Regional Outlook (Revenue, USD Million, 2021- 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion in the scope of cell culture technology
      • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
      • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control in cell culture techniques
      • 3.2.2.2. Scalability issues with culturing methods
      • 3.2.2.3. Ethical concerns regarding use of animals
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Cell Culture Market: Product Movement Analysis
  • 4.3. Consumables
    • 4.3.1. Global Consumables Market, 2021 - 2033 (USD Million)
    • 4.3.2. Media
      • 4.3.2.1. Global media market, 2021 - 2033 (USD Million)
      • 4.3.2.2. Serum-free media
        • 4.3.2.2.1. Global serum-free media market, 2021 - 2033 (USD Million)
        • 4.3.2.2.2. CHO media
          • 4.3.2.2.2.1. Global CHO media market, 2021 - 2033 (USD Million)
        • 4.3.2.2.3. BHK medium
          • 4.3.2.2.3.1. Global BHK medium market, 2021 - 2033 (USD Million)
        • 4.3.2.2.4. Vero medium
          • 4.3.2.2.4.1. Global Vero medium market, 2021 - 2033 (USD Million)
        • 4.3.2.2.5. HEK 293 Media
          • 4.3.2.2.5.1. Global HEK 293 media market, 2021 - 2033 (USD Million)
        • 4.3.2.2.6. Other serum-free media
          • 4.3.2.2.6.1. Global other serum-free media market, 2021 - 2033 (USD Million)
      • 4.3.2.3. Classical media
        • 4.3.2.3.1. Global classical media market, 2021 - 2033 (USD Million)
      • 4.3.2.4. Stem cell culture media
        • 4.3.2.4.1. Global stem cell culture media market, 2021 - 2033 (USD Million)
      • 4.3.2.5. Specialty media
        • 4.3.2.5.1. Global specialty media market, 2021 - 2033 (USD Million)
      • 4.3.2.6. Chemically defined media
        • 4.3.2.6.1. Global chemically defined media market, 2021 - 2033 (USD Million)
      • 4.3.2.7. Other cell culture media
        • 4.3.2.7.1. Global other cell culture media market, 2021 - 2033 (USD Million)
    • 4.3.3. Sera
      • 4.3.3.1. Global sera market, 2021 - 2033 (USD Million)
      • 4.3.3.2. Fetal bovine serum
        • 4.3.3.2.1. Global fetal bovine serum market, 2021 - 2033 (USD Million)
      • 4.3.3.3. Others
        • 4.3.3.3.1. Global others market, 2021 - 2033 (USD Million)
    • 4.3.4. Reagents
      • 4.3.4.1. Global reagents market, 2021 - 2033 (USD Million)
      • 4.3.4.2. Albumin
        • 4.3.4.2.1. Global albumin market, 2021 - 2033 (USD Million)
      • 4.3.4.3. Others
        • 4.3.4.3.1. Global others market, 2021 - 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Global instruments market, 2021 - 2033 (USD Million)
    • 4.4.2. Culture systems
      • 4.4.2.1. Global culture systems market, 2021 - 2033 (USD Million)
    • 4.4.3. Incubators
      • 4.4.3.1. Global incubators market, 2021 - 2033 (USD Million)
    • 4.4.4. Centrifuges
      • 4.4.4.1. Global centrifuges market, 2021 - 2033 (USD Million)
    • 4.4.5. Cryostorage equipment
      • 4.4.5.1. Global cryostorage equipment market, 2021 - 2033 (USD Million)
    • 4.4.6. Biosafety equipment
      • 4.4.6.1. Global biosafety equipment market, 2021 - 2033 (USD Million)
    • 4.4.7. Pipetting instruments
      • 4.4.7.1. Global pipetting instruments market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Cell Culture Market: Application Movement Analysis
  • 5.3. Biopharmaceutical Production
    • 5.3.1. Global Biopharmaceutical Production Market, 2021 - 2033 (USD Million)
    • 5.3.2. Monoclonal antibodies
      • 5.3.2.1. Monoclonal antibodies market, 2021 - 2033 (USD Million)
    • 5.3.3. Vaccines production
      • 5.3.3.1. Global vaccines production market, 2021 - 2033 (USD Million)
    • 5.3.4. Other therapeutic proteins
      • 5.3.4.1. Global other therapeutic proteins market, 2021 - 2033 (USD Million)
  • 5.4. Drug Development
    • 5.4.1. Global drug development market, 2021 - 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Global diagnostics market, 2021 - 2033 (USD Million)
  • 5.6. Tissue Culture & Engineering
    • 5.6.1. Global tissue culture & engineering, 2021 - 2033 (USD Million)
  • 5.7. Cell & Gene Therapy
    • 5.7.1. Global cell and gene therapy market, 2021 - 2033 (USD Million)
  • 5.8. Toxicity Testing
    • 5.8.1. Global toxicity testing market, 2021 - 2033 (USD Million)
  • 5.9. Other Applications
    • 5.9.1. Global other applications market, 2021 - 2033 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Culture Market Share by Region, 2025 & 2033
  • 6.2. North America
    • 6.2.1. North America Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Mexico Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Argentina Cell Culture Market, 2021 - 2033 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Culture Market, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Culture Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2025
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Corning Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Avantor Inc.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BD
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Eppendorf SE
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Bio-Techne
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. PromoCell GmbH
      • 7.4.10.1. Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제